- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
7 result(s) found for: Apnea of prematurity.
Displaying page 1 of 1.
EudraCT Number: 2015-003274-32 | Sponsor Protocol Number: 2015/233 | Start Date*: 2016-07-13 |
Sponsor Name:Dra Maria Luz Couce [...] | ||
Full Title: Effect of caffeine citrate in acute bronchiolitis symptoms of apnea in neonates and infants during the first three months of life | ||
Medical condition: Children under 3 years with acute RSV bronchiolitis which present breaks apnea | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003666-41 | Sponsor Protocol Number: MEC2020-0078 | Start Date*: 2020-04-21 | |||||||||||
Sponsor Name:Erasmus MC University Medical Center | |||||||||||||
Full Title: Doxapram versus placebo in preterm newborns: an international double blinded multicenter randomized controlled trial. | |||||||||||||
Medical condition: Preterm infants are at high risk of respiratory failure due to immaturity of the respiratory system. Respiratory failure is caused by a comprised lung function and impaired control of breathing. Co... | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Trial now transitioned) BE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-005568-24 | Sponsor Protocol Number: NL47657-044-14 | Start Date*: 2014-05-28 |
Sponsor Name:Medisch Spectrum Twente | ||
Full Title: The reduction of Apneas in Preterm Infants: Low-Flow versus Caffeine | ||
Medical condition: Apnea Of Prematurity | ||
Disease: | ||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010381-30 | Sponsor Protocol Number: 2.4 | Start Date*: 2009-03-19 | |||||||||||
Sponsor Name:Isala klinieken | |||||||||||||
Full Title: Aerosolised salbutamol in two doses as a treatment for preterm infants with developing bronchopulmonary dysplasia. | |||||||||||||
Medical condition: Preterm infants developing bronchopulmonary dysplasia | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-023668-42 | Sponsor Protocol Number: CRI 102194 | Start Date*: 2011-02-03 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Southampton University Hospital NHS Trust | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Pulmonary surfactant (S) biology in ventilated children on a paediatric intensive care unit with acute (A) hypoxic respiratory (R) failure- a pilot (P) study (S): (SARPS) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: acute hypoxic respiratory failure in children ventilated on paediatric intensive care | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000811-23 | Sponsor Protocol Number: | Start Date*: 2012-06-22 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:University Hospital Southampton NHS Foundation Trust | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Treatment of neonatal chronic lung disease (nCLD). The Surfactant, Nutrition and Microorganism Interactions study in infants at risk of developing chronic lung disease - 2 (TSuNaMI-II) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: neonatal chronic lung disease bronchopulmonary dysplasia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001849-41 | Sponsor Protocol Number: DOX-101 | Start Date*: 2012-06-18 | |||||||||||
Sponsor Name:Leids Universitair Medisch Centrum (LUMC) | |||||||||||||
Full Title: Two-part, Randomized, Placebo-controlled, Repeated Stepped Infusion Dose Study of the Pharmacodynamics of Doxapram when Co-administered with Opioids (Protocol – doxapram-101). | |||||||||||||
Medical condition: acute respiratory insufficiency, including such conditions as opioid and anesthetic-induced respiratory depression, post-anesthetic atelectasis, and central apneas (e.g., apnea of prematurity). | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
